CVX — Carvolix Share Price
Last trade - 00:00- €119.23m
- €135.23m
- €4.12m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 5.65 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 28.95 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -30.73% | ||
| Return on Equity | -62.5% | ||
| Operating Margin | -362.38% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | n/a | n/a | n/a | n/a | 4.12 | n/a | 2.2 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Carvolix is a France-based company. The Company is engaged in developing Artificial Intelligence (AI)‑driven autonomous mini‑robots and biomimetic implants for interventional cardiology and stroke treatment. It operates through the consolidation, Caranx Medical, and Artedrone, and focuses on technologies used in cardiac valve replacement, structural heart interventions, and neurovascular procedures. It develops systems combining micro‑robotics, artificial intelligence, imaging guidance, and implantable heart devices. Its product portfolio includes the TAVIPILOT software for transcatheter aortic valve implantation (TAVI), structural heart devices such as Kalios and Epygon, the Artus artificial urinary sphincter, and a robotic platform intended for stroke treatment.
Directors
- Michel Finance CHM
- Jerome Geoffroy CFO
- Olivier Pierron COO (45)
- Eric Jague OTH
- Francois Laborde OTH
- Pascale Lagrange OTH
- Claire Corot DRC
- Patrick Coulombier DRC
- Daniel Hayoz DRC
- Philippe Pouletty DRC (64)
- Dominique Carouge IND
- Soad Ghazouani IND
- Veronique Phe IND
- Ellen Roche IND
- Last Annual
- December 31st, 2024
- Last Interim
- June 30th, 2025
- Incorporated
- February 6th, 2018
- Public Since
- June 14th, 2021
- No. of Employees
- 76
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Euronext - Paris
- Shares in Issue
- 39,348,313
- Address
- 320 avenue Archimede, AIX-EN-PROVENCE, 13100
- Web
- https://www.affluentmedical.com/
- Phone
- +33 442951220
- Contact
- Sebastien Ladet
- Auditors
- PricewaterhouseCoopers Audit
Upcoming Events for CVX
Similar to CVX
AbL Diagnostics SA
Euronext - Paris
Aton SA
Euronext - Paris
Biomerieux SA
Euronext - Paris
Biosynex SA
Euronext - Paris
Bluelinea SA
Euronext - Paris
FAQ
As of Today at 09:49 UTC, shares in Carvolix are trading at €3.03. This share price information is delayed by 15 minutes.
Shares in Carvolix last closed at €3.03 and the price had moved by +116.43% over the past 365 days. In terms of relative price strength the Carvolix share price has outperformed the FTSE Global All Cap Index by +97.86% over the past year.
The overall consensus recommendation for Carvolix is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreCarvolix does not currently pay a dividend.
Carvolix does not currently pay a dividend.
Carvolix does not currently pay a dividend.
To buy shares in Carvolix you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €3.03, shares in Carvolix had a market capitalisation of €119.23m.
Here are the trading details for Carvolix:
- Country of listing: France
- Exchange: PAR
- Ticker Symbol: CVX
Based on an overall assessment of its quality, value and momentum Carvolix is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Carvolix is €4.30. That is 41.91% above the last closing price of €3.03.
Analysts covering Carvolix currently have a consensus Earnings Per Share (EPS) forecast of -€0.47 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Carvolix. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +78.28%.
As of the last closing price of €3.03, shares in Carvolix were trading +67.71% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Carvolix PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €3.03.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Carvolix's management team is headed by:
- Michel Finance - CHM
- Jerome Geoffroy - CFO
- Olivier Pierron - COO
- Eric Jague - OTH
- Francois Laborde - OTH
- Pascale Lagrange - OTH
- Claire Corot - DRC
- Patrick Coulombier - DRC
- Daniel Hayoz - DRC
- Philippe Pouletty - DRC
- Dominique Carouge - IND
- Soad Ghazouani - IND
- Veronique Phe - IND
- Ellen Roche - IND